Completed
A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection
NCT04639466
- Conditions
- COVID-19, COVID-19 Infection, Coronaviridae Infections, +10 more
- Locations
-
- EmVenio Research Claremont, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Millennium Clinical Trials Thousand Oaks, California, United States